A phase 1 trial of MURA-8518
Latest Information Update: 16 Jan 2025
Price :
$35 *
At a glance
- Drugs MURA 8518 (Primary)
- Indications Solid tumours
- Focus Adverse reactions
- 10 Jan 2025 New trial record
- 09 Jan 2025 According to a Mural Oncology media release, company expects to submit an IND or CTA for a phase 1 trial of MURA-8518 in Q4 2025.